Angion Biomedica (ANGN) PT Lowered to $5 at Stifel

December 10, 2021 6:22 AM EST Send to a Friend
Stifel analyst Annabel Samimy lowered the price target on Angion Biomedica (NASDAQ: ANGN) to $5.00 (from $15.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login